(NP (NP (NN Objective)) (: :) (S (NP (NNP Anemia)) (VP (VBZ is) (NP (NP (DT a) (JJ frequent) (NN comorbidity)) (PP (IN in) (NP (NN hemodialysis) (NNS patients))) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (ADVP (RB successfully)) (VBN treated) (PP (IN by) (S (VP (VBG administering) (NP (NP (JJ erythropoiesis-stimulating) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NNP ESAs)) (-RRB- -RRB-)))))))))))))) (. .))
(S (NP (NNP ESAs) (NN dosing)) (VP (VBZ is) (ADVP (RB currently)) (VP (VBN based) (PP (IN on) (NP (NP (JJ clinical) (NNS protocols)) (SBAR (WHNP (WDT that)) (S (ADVP (RB often)) (VP (VBP do) (RB not) (VP (VB account) (PP (IN for) (NP (NP (DT the) (JJ high) (ADJP (JJ inter-) (CC and) (JJ intra-individual)) (NN variability)) (PP (IN in) (NP (NP (DT the) (NN patient) (POS 's)) (NN response))))))))))))) (. .))
(S (PP (IN As) (NP (DT a) (NN result))) (, ,) (NP (NP (DT the) (JJ hemoglobin) (NN level)) (PP (IN of) (NP (DT some) (NNS patients)))) (VP (VBZ oscillates) (PP (IN around) (NP (NP (DT the) (NN target) (NN range)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (JJ multiple) (NNS risks) (CC and) (NNS side-effects)))))))))) (. .))
(S (NP (DT This) (NN work)) (VP (VBZ proposes) (NP (NP (DT a) (NN methodology)) (VP (VBN based) (PP (IN on) (NP (NP (NN reinforcement) (NN learning)) (PRN (-LRB- -LRB-) (NP (NNP RL)) (-RRB- -RRB-))))) (SBAR (S (VP (TO to) (VP (VB optimize) (NP (NNP ESA) (NN therapy)))))))) (. .))
(NP (NP (NNS Methods)) (: :) (S (NP (NNP RL)) (VP (VBZ is) (NP (NP (DT a) (JJ data-driven) (NN approach)) (PP (IN for) (S (VP (VBG solving) (NP (NP (JJ sequential) (NN decision-making) (NNS problems)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN formulated) (PP (IN as) (NP (NP (NNP Markov) (NN decision) (NNS processes)) (PRN (-LRB- -LRB-) (NP (NNP MDPs)) (-RRB- -RRB-))))))))))))))) (. .))
(S (S (VP (VBG Computing) (NP (NP (JJ optimal) (NN drug) (NN administration) (NNS strategies)) (PP (IN for) (NP (JJ chronic) (NNS diseases)))))) (VP (VBZ is) (NP (NP (DT a) (JJ sequential) (NN decision-making) (NN problem)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT the) (NN goal)) (VP (VBZ is) (S (VP (TO to) (VP (VB find) (NP (NP (DT the) (JJS best) (NN sequence)) (PP (IN of) (NP (NN drug) (NNS doses)))))))))))) (. .))
(S (NP (NNP MDPs)) (VP (VBP are) (ADJP (RB particularly) (JJ suitable) (PP (IN for) (S (VP (VBG modeling) (NP (DT these) (NNS problems)))))) (PP (VBP due) (TO to) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB capture) (NP (NP (NP (DT the) (NN uncertainty)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN outcome)) (PP (IN of) (NP (DT the) (NN treatment))))))) (CC and) (NP (NP (DT the) (JJ stochastic) (NN nature)) (PP (IN of) (NP (DT the) (JJ underlying) (NN process))))))))))) (. .))
(S (NP (NP (DT The) (NNP RL) (NN algorithm)) (VP (VBN employed) (PP (IN in) (NP (DT the) (VBN proposed) (NN methodology))))) (VP (VBZ is) (NP (NP (VBN fitted) (NNP Q) (NN iteration)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ stands) (PRT (RP out)) (PP (IN for) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB make) (NP (NP (DT an) (JJ efficient) (NN use)) (PP (IN of) (NP (NNS data)))))))))))))) (. .))
(NP (NP (NNS Results)) (: :) (S (NP (NP (DT The) (NNS experiments)) (VP (VBN reported) (ADVP (RB here)))) (VP (VBP are) (VP (VBN based) (PP (IN on) (NP (NP (DT a) (JJ computational) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (VBZ describes) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NNP ESAs))) (PP (IN on) (NP (DT the) (NN hemoglobin) (NN level)))))))))))) (. .))
(S (NP (NP (DT The) (NN performance)) (PP (IN of) (NP (DT the) (VBN proposed) (NN method)))) (VP (VBZ is) (VP (VP (VBN evaluated)) (CC and) (VP (VBN compared) (PP (PP (IN with) (NP (DT the) (JJ well-known) (JJ Q-learning) (NN algorithm))) (CC and) (PP (IN with) (NP (DT a) (JJ standard) (NN protocol))))))) (. .))
(S (NP (NN Simulation) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NNP Q-learning)))) (VP (VBZ is) (ADJP (ADJP (RB substantially) (JJR lower)) (PP (IN than) (NP (NP (NNP FQI)) (CC and) (NP (DT the) (NN protocol))))))))) (. .))
(NP (NP (NN Conclusion)) (: :) (S (SBAR (IN Although) (S (NP (JJ prospective) (NN validation)) (VP (VBZ is) (VP (VBN required))))) (, ,) (NP (VBG promising) (NNS results)) (VP (VBP demonstrate) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NNP RL))) (S (VP (TO to) (VP (VB become) (NP (NP (DT an) (JJ alternative)) (PP (TO to) (NP (JJ current) (NNS protocols)))))))))) (. .))
